ACS Medicinal Chemistry Letters
Page 6 of 7
date. Expert Opin. Pharmacother. 2014, 15, 1403ꢀ1415. (c) Sun, Y.;
(24) Fujii, S.; Hashimoto, Y.; Suzuki, T.; Ohta. S.; Endo, Y. A
Fang, M.; Davies, H.; Hu, Z. Mifepristone: a potential clinical agent
based on its antiꢀprogesterone and antiꢀglucocorticoid properties.
Gynecol. Endocrinol. 2014, 30, 169–173. (d) Bestel, E.; Donnez, J.
The potential of selective progesterone receptor modulators for the
treatment of uterine fibroids. Expert Rev. Endocrinol. Metab. 2014, 9,
79ꢀ92. (e) ChabbertꢀBuffet, N.; Meduri, G.; Bouchard, P.; Spitz, I. M.
Selective progesterone receptor modulators and progesterone antagoꢀ
nists: mechanisms of action and clinical applications. Hum. Reprod.
Update 2005, 11, 293–307.
(15) Zhang, P.; Terefenko, E. A.; Fensome, A.; Wrobel, J.; Winꢀ
neker, R.; Lundeen, S.; Marschke, K. B.; Zhang Z. 6ꢀArylꢀ1,4ꢀ
dihydroꢀbenzo[d][1,3]oxazinꢀ2ꢀones: a novel class of potent, selecꢀ
tive, and orally active nonsteroidal progesterone receptor antagonists.
J. Med. Chem. 2002, 45, 4379– 4382.
(16) Fensome, A.; Adams,W.R.; Adams, A. L.; Berrodin, T. J.;
Cohen, J.; Huselton, C.; Illenberger, A.; Kern, J. C.; Hudak, V. A.;
Marella, M. A.; Melenski, E. G.; McComas, C. C.; Mugford, C. A.;
Slayden, O. D.; Yudt, M.; Zhang, Z.; Zhang, P.; Zhu, Y.; Winneker,
R. C.; Wrobel, J. E. Design, synthesis, and SAR of new pyrroleꢀ
oxindole progesterone receptor modulators leading to 5ꢀ(7ꢀfluoroꢀ3,3ꢀ
dimethylꢀ2ꢀoxoꢀ2,3ꢀdihydroꢀ1Hꢀindolꢀ5ꢀyl)ꢀ1ꢀmethylꢀ1Hꢀpyrroleꢀ2ꢀ
carbonitrile WAYꢀ255348). J. Med. Chem. 2008, 51, 1861–1873.
(17) Sakai, H.; Hirano, T.; Mori, S.; Fujii, S.; Masuno, H.; Kinoshiꢀ
ta, M.; Kagechika, H.; Tanatani, A. 6ꢀArylcoumarins as novel nonꢀ
steroidal type progesterone antagonists: an example with receptor
bindingꢀdependent fluorescence. J. Med. Chem. 2011, 54, 7055ꢀ7065.
(18) Winneker, R. C.; Fensome, A.; Zhang, P.; Yudt, M. R.;
McComas, C. C.; Unwalla, R. J. A new generation of progesterone
receptor modulators. Steroids 2008, 73, 689ꢀ701.
(19) Fujii, S.; Yamada, A.; Nakano, E.; Takeuchi, Y.; Mori, S.;
Masuno, H.; Kagechika, H. Design and synthesis of nonsteroidal
progesterone receptor antagonists based on C,C’ꢀdiphenylcarborane
scaffold as a hydrophobic pharmacophore. Eur. J. Med. Chem. 2014,
84, 264ꢀ277.
(20) Fujii, S.; Nakano, E.; Yanagida, N.; Mori, S.; Masuno, H.;
Kagechika, H. Development of pꢀcarboraneꢀbased nonsteroidal proꢀ
gesterone receptor antagonists. Bioorg. Med. Chem. 2014, 22, 5329–
5337.
(21) Collins, M. A.; Hudak, V.; Bender, R.; Fensome, A.; Zhang,
P.; Miller, L.; Winneker, R. C.; Zhang, Z.; Zhu, Y.; Cohen, J.; Unwalꢀ
la, R. J.; Wrobel, J. Novel pyrroleꢀcontaining progesterone receptor
modulators. Bioorg. Med. Chem. Lett. 2004, 14, 2185–2189.
(22) Gao, W.; Bohl, C. E.; Dalton, J. T. Chemistry and biology of
androgen receptor. Chem. Rev. 2005, 105, 3352ꢀ3370.
(23) Fujii, S.; Goto, T.; Ohta, K.; Hashimoto, Y.; Suzuki, T.; Ohta,
S.; Endo, Y. Potent androgen antagonists based on carborane as a
hydrophobic core structure. J. Med. Chem. 2005, 48, 4654ꢀ4662.
New class of androgen receptor antagonists bearing carborane in
place of a steroidal skeleton. Bioorg. Med. Chem. Lett. 2005, 15, 227ꢀ
230.
1
2
3
4
5
6
7
8
(25) Inoue, K.; Urushibara, K.; Kanai, M.; Yura, K.; Fujii, S.;
Hashimoto, Y.; IshigamiꢀYuasa, M.; Mori, S.; Kawachi, E.; Matsuꢀ
mura, M.; Hirano, T.; Kagechika, H.; Tanatani, A. Design and syntheꢀ
sis of 4ꢀbenzylꢀ1ꢀ(2H)ꢀphthalazinone derivatives as novel androgen
receptor antagonists. Eur. J. Med. Chem. 2015, 102, 310ꢀ319.
(26) Yamada, A.; Fujii, S.; Mori, S.; Kagechika, H. Design and
synthesis of 4ꢀ(4ꢀbenzoylaminophenoxy)phenol derivatives as androꢀ
gen receptor antagonists. ACS Med. Chem. Lett. 2013, 4, 937ꢀ941.
(27) Lorenzo, D. D.; Albertini, A.; Zava, D. Progestin regulation of
alkaline phosphatase in the human breast cancer cell line T47D. Can-
cer Res. 1991, 51, 4470ꢀ4475.
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(28) Li, Z.; Langhans, S. A. Transcriptional regulators of Na,Kꢀ
ATPase subunits. Front. Cell Dev. Biol., 2015, 3, 66.
(29) Hiraoka, D.; Nakamura, N.; Nishizawa, Y.; Uchida, N.; Noguꢀ
chi, S.; Matsumoto, K.; Sato, B. Inhibitory and stimulatory effects of
glucocorticoid on androgenꢀinduced growth of murine Shionogi carꢀ
cinoma 115 in vivo and in cell culture. Cancer Res. 1987, 47, 6560–
6564.
(30) Adsmond, D. A.; Grant, D. J. W. Hydrogen bonding in sulꢀ
fonamides. J. Pharm. Sci. 2001, 90, 2058ꢀ2077.
(31) Azumaya, I.; Kato, T.; Okamoto, I.; Yamasaki, R.; Tanatani,
A.; Yamaguchi, K.; Kagechika, H.; Takayanagi, H. Absolute helical
arrangement of sulfonamide in the crystal. Org. Lett. 2003, 5,
3939−3942.
(32) Kashino, S.; Ito, K.; Haisa, M. The crystal and molecular
structure of benzanilide. Bull. Chem. Soc. Jpn. 1979, 52, 365ꢀ369.
(33) Raaijmakers, H. C. A.; Versteegh, J. E.; Uitdehaag, J. C. M.
The Xꢀray structure of RU486 bound to the progesterone receptor in a
destabilized agonistic conformation. J. Biol. Chem. 2009, 284, 19572ꢀ
19579.
(34) Morris, G. M.; Huey, R.; Lindstrom, W.; Sanner, M. F.; Beꢀ
lew, R. K.; Goodsell, D. S.; Olson, A. J. Autodock4 and AutoDockꢀ
Tools4: automated docking with selective receptor flexibility. J.
Comput. Chem. 2009, 30, 2785-2791.
ACS Paragon Plus Environment